Pages Menu
FacebookTwitterPinterestRss
Categories Menu

Posted by on Jul 6, 2016 in Foundation NewsLine |

Genzyme Update

The NNPDF Central Office has received the following
press release from Genzyme:

Sanofi Genzyme Begins Pivotal Phase
2/3 Trial of Olipudase Alfa for Adult Patients
with Acid Sphingomyelinase Deficiency

CLICK HERE FOR FULL REPORT